Login to Your Account



Acambis Suspends Enrollment In Smallpox Vaccine Pivotal Program

By Kim Coghill


Wednesday, April 14, 2004
Government contractor Acambis plc suspended recruitment of additional volunteers in a Phase III program evaluating its smallpox vaccine candidate against Dryvax, after three out of 2,800 participants showed signs of heart inflammation. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription